ATE87662T1 - Antidiabetikaverbindungen. - Google Patents

Antidiabetikaverbindungen.

Info

Publication number
ATE87662T1
ATE87662T1 AT85304162T AT85304162T ATE87662T1 AT E87662 T1 ATE87662 T1 AT E87662T1 AT 85304162 T AT85304162 T AT 85304162T AT 85304162 T AT85304162 T AT 85304162T AT E87662 T1 ATE87662 T1 AT E87662T1
Authority
AT
Austria
Prior art keywords
diabetic compounds
compounds
present
diabetic
insulin
Prior art date
Application number
AT85304162T
Other languages
English (en)
Inventor
Bruce Hill Frank
Allen Howard Pekar
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE87662T1 publication Critical patent/ATE87662T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT85304162T 1984-06-14 1985-06-12 Antidiabetikaverbindungen. ATE87662T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/620,780 US4569792A (en) 1984-06-14 1984-06-14 Anti-diabetic compounds
EP85304162A EP0171886B1 (de) 1984-06-14 1985-06-12 Antidiabetikaverbindungen

Publications (1)

Publication Number Publication Date
ATE87662T1 true ATE87662T1 (de) 1993-04-15

Family

ID=24487358

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85304162T ATE87662T1 (de) 1984-06-14 1985-06-12 Antidiabetikaverbindungen.

Country Status (8)

Country Link
US (1) US4569792A (de)
EP (1) EP0171886B1 (de)
JP (1) JPH0633318B2 (de)
AT (1) ATE87662T1 (de)
CA (1) CA1244366A (de)
DE (1) DE3587227T2 (de)
DK (1) DK262485A (de)
MX (1) MX9203125A (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888414A (en) * 1987-04-09 1989-12-19 Board Of Regents, University Of Texas System Insulin-binding peptides and uses thereof
US4992417A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogues
US4992418A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
US5208217A (en) * 1989-04-20 1993-05-04 Mount Sinai School Of Medicine Of The City University Of New York Hepatospecific insulin analogues
US5130236A (en) * 1989-12-07 1992-07-14 Eli Lilly And Company Process for producing des(64,65)-proinsulin
US5650489A (en) * 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
CZ342492A3 (en) * 1991-11-26 1993-06-16 Lilly Co Eli Derivatives of tri-arginine insulin, process of their preparation and a pharmaceutical composition in which said derivatives are comprised
CA2213301C (en) 1995-02-20 2010-01-26 Amrad Operations Pty. Ltd. Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm)
WO2001072323A2 (en) 2000-03-24 2001-10-04 Genentech, Inc. Use of insulin for the treatment of cartilagenous disorders
US20120090873A1 (en) 2009-06-19 2012-04-19 Gundel Douglas B Shielded electrical cable
US9685259B2 (en) 2009-06-19 2017-06-20 3M Innovative Properties Company Shielded electrical cable
TWI400376B (zh) * 2010-06-25 2013-07-01 Inprotex Co Ltd Sun light can cloth
CN101906696B (zh) * 2010-07-16 2012-09-19 吴国林 防晒光能布
KR20200080747A (ko) * 2018-12-27 2020-07-07 주식회사 폴루스 인슐린 전구체의 인슐린 효소 전환용 조성물 및 이를 이용하여 인슐린 전구체를 인슐린으로 전환하는 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4430266A (en) 1980-11-28 1984-02-07 Eli Lilly And Company Process for producing an insulin precursor
DE3209184A1 (de) * 1982-03-13 1983-09-15 Hoechst Ag, 6230 Frankfurt Verfahren zur umwandlung von praeproinsulinanaloga zu insulinen
EP0090433A1 (de) * 1982-03-31 1983-10-05 Genetics Institute, Inc. Herstellung von modifizierten Proinsulin-Vorläufer codierenden DNA-Sequenzen

Also Published As

Publication number Publication date
DK262485A (da) 1985-12-15
DE3587227T2 (de) 1993-08-12
JPH0633318B2 (ja) 1994-05-02
US4569792A (en) 1986-02-11
DK262485D0 (da) 1985-06-12
EP0171886A3 (en) 1989-01-25
DE3587227D1 (de) 1993-05-06
CA1244366A (en) 1988-11-08
JPS6133198A (ja) 1986-02-17
EP0171886B1 (de) 1993-03-31
EP0171886A2 (de) 1986-02-19
MX9203125A (es) 1992-07-01

Similar Documents

Publication Publication Date Title
ATE86668T1 (de) Antidiabetikaverbindungen.
EG15458A (en) Improvements in or relating to 3-aryloxy-3-phenylpropylamines
NL981005I2 (nl) Microbiocide middelen.
DK0486948T3 (da) Forbindelser, der hæmmer retrovirale proteaser
IT8919413A0 (it) Composizione avente attivita' battericida oppure batteriostatica.
ATE87662T1 (de) Antidiabetikaverbindungen.
DE3585980D1 (de) Hydrazinderivate und ihre verwendung.
FI863836A0 (fi) Kinolinderivat.
ATE87661T1 (de) Antidiabetikaverbindungen.
IT8422150A0 (it) Composti dotati di attivita'antiallergica.
DE3575681D1 (de) Dispergierende salze.
SU1095611A1 (ru) Хлорид 5-хлорметил-2-этил-8-метил-4Н-м-диоксино-(4,5-с)-пиридиния, обладающий антимикробной активностью
DE3577899D1 (de) Cyanuersaeure enthaltende waessrige zusammensetzungen.
IT8522424A0 (it) Composto ad attivita'pilostimolante.
IT8420075A0 (it) Composti ad attivita'antibatterica.
SU1319521A1 (ru) 5-(2,2,2-Трифтор-1-окси-1-трифторметилэтил)фурил-2-метилгидразонийбромид, проявляющий антимикробную и противовоспалительную активность
SU1005420A1 (ru) S-(5-Нитрофурфурил-2)-тиуроний бромид, обладающий антимикробной активностью
SU1202241A1 (ru) Натриевая соль 5-n-хлорбензилидентиазолидиндиона-2,4, обладающая противогрибковой активностью
SU1302661A1 (ru) 3-(3,5-Диметилпиразолил-1)-6-(2-карбэтокси-1-метилэтилиден-1)гидразинопиридазин, обладающий противовоспалительной и противомикробной активностью
SU1455632A1 (ru) О,о-диэтил-n-(1-пропилтио-2-гидрокси-2-метилпропилиден)-амидотиофосфат, обладающий бактерицидной активностью
SU1221874A1 (ru) 1,1-Этилиденди-(5-нитро-2-фуроиламин), проявляющий противомикробную и противовоспалительную активность
SU1127273A1 (ru) о-Триэтилсилоксибензальдоксим, обладающий холеретической и противомикробной активностью
SU1374724A1 (ru) 1-фосфонометил-2-иминоимидазолидин-4-он, обладающий гербицидной активностью
SU961332A1 (ru) [5-(2,2-Диметил-4,6-диоксо-1,3-диоксан-5-метенил)фурил-2]-(бензотиазолил-2) сульфид, проявляющий антимикробную активность
SU1610823A1 (ru) S-трет-бутилтиуронийбромид, обладающий антиишемической активностью

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee